Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
2.2 Definitions
13
2.2.1 Drug delivery devices 13
3 Healthcare Sector Review 15
3.1 Healthcare Sector Review 15
3.2 Healthcare Expenditure 15
3.3
Healthcare Infrastructure 16
3.4 Healthcare Policy 17
4 Drug Delivery
Devices in United Kingdom 19
4.1 Drug Delivery Devices Overall Revenues
(2000-2012) 19
4.2 Drug Delivery Devices Overall Volume (2000-2012) 25
4.3 Drug Delivery Devices Company Shares (2005-2006) 28
5 Inhalation
Systems in United Kingdom 29
5.1 Inhalation Systems Overall Revenues
(2000-2012) 29
5.1.1 Metered Dose Inhaler Devices Overall Revenues
(2000-2012) 33
5.1.2 Dry Powder Inhaler Devices Overall Revenues
(2000-2012) 35
5.2 Inhalation Systems Overall Volume (2000-2012) 37
5.2.1 Metered Dose Inhaler Devices Overall Volume (2000-2012) 39
5.2.2 Dry
Powder Inhaler Devices Overall Volume (2000-2012) 41
5.3 Inhalation
Systems Average Price (2000-2012) 43
5.3.1 Metered Dose Inhaler Devices
Average Price (2000-2012) 43
5.3.2 Dry Powder Inhaler Devices Average
Price (2000-2012) 45
5.4 Inhalation Systems Distribution Share (2005-2006)
47
5.5 Inhalation Systems Company Share (2005-2006) 48
6 Infusion
Systems in United Kingdom 49
6.1 Infusion Systems Overall Revenues
(2000-2012) 49
6.1.1 Infusion Disposable Sets Overall Revenue (2000-2012)
53
6.1.2 Infusion Pumps Overall Revenue (2000-2012) 55
6.1.3 Syringe
Pumps Overall Revenues (2000-2012) 57
6.2 Infusion Systems Overall Volume
(2000-2012) 59
6.2.1 Infusion Disposable Sets Overall Volume (2000-2012)
60
6.2.2 Infusion Pumps Overall Volume (2000-2012) 62
6.2.3 Syringe
Pumps Overall Volume (2000-2012) 64
6.3 Infusion Systems Average Price
(2000-2012) 66
6.3.1 Infusion Pumps Average Price (2000-2012) 66
6.3.2
Syringe Pumps Average Price (2000-2012) 68
6.3.3 Infusion Disposable Sets
Average Price (2000-2012) 70
6.4 Infusion Systems Distribution Share
(2005-2006) 72
6.5 Infusion Systems Company Share (2005-2006) 73
7
Needle Free Injections in United Kingdom 74
7.1 Needle Free Injections
Overall Revenue (2000-2012) 74
7.2 Needle Free Injections Overall Volume
(2000-2012) 76
7.3 Needle Free Injections Average Price (2000-2012) 78
7.4 Needle Free Injections Distribution Share (2005-2006) 80
7.5 Needle
Free Injections Company Share (2005-2006) 81
8 AstraZeneca PLC Company
Profile 82
8.1 Company Overview 82
8.2 Business Overview 82
8.2.1
Products 83
8.2.2 History 84
8.3 Locations And Subsidiaries 85
9
3M Company Profile 87
9.1 Company Overview 87
9.2 Business Overview
87
9.2.1 Consumer and Office 87
9.2.2 Display and Graphics 88
9.2.3 Electro and Communications 88
9.2.4 Health Care 89
9.2.5
Industrial and Transportation 90
9.2.6 Safety, Security and Protection
Services 90
9.2.7 Products 91
9.3 Value Chain Analysis 93
9.3.1
Manufacturing 93
9.3.2 Product Development 93
9.3.3 Sales and
Marketing 94
9.4 SWOT Analysis 95
9.4.1 3M Company Strengths 95
3M
Company Weaknesses 96
3M Company Opportunities 96
3M Company Threats
97
9.5 Revenue Analysis 97
9.5.1 Revenue by Segment 98
9.5.2
Revenue by Geography 98
9.6 Financial and Operational Review 100
9.6.1
Financial Statements 100
9.6.2 Financial Ratios 101
9.7 Locations And
Subsidiaries 102
10 Baxter International Company Profile 103
10.1
Company Overview 103
10.2 Business Overview 103
10.2.1 BioScience
103
10.2.2 Medication Delivery 103
10.2.3 Renal 104
10.2.4
Products 104
10.2.5 History 105
10.3 Value Chain Analysis 107
10.3.1 Manufacturing 108
10.3.2 Product Development 108
10.3.3 Sales
and Marketing 109
10.4 SWOT Analysis 109
10.4.1 Baxter International
Inc. Strengths 110
10.4.2 Baxter International Inc. Weaknesses 110
10.4.3 Baxter International Inc. Opportunities 111
10.4.4 Baxter
International Inc. Threats 111
10.5 Revenue Analysis 112
10.5.1
Revenue by Segment 112
10.5.2 Revenue by Geography 113
10.6 Financial
and Operational Review 114
10.6.1 Financial Statements 114
10.6.2
Financial Ratios 115
10.7 Locations And Subsidiaries 116
10.8 Baxter
International Inc. Pipeline Products 117
10.8.1 Next-Generation Home
Hemodialysis Machine 117
11 GlaxoSmithKline plc Company Profile 119
11.1 Company Overview 119
11.2 Business Overview 119
11.2.1 Products
120
11.2.2 History 120
11.3 Locations And Subsidiaries 122
12
Novartis AG Company Profile 124
12.1 Company Overview 124
12.2
Business Overview 124
12.2.1 Major Products and Services 125
12.3
Locations And Subsidiaries 126
13 Regulation System 128
13.1 Medical
Equipment Approval Process 128
13.1.1 Classification of Medical Devices
128
13.1.2 Conformity Assessment Process 136
13.2 Medical Device
approval fee 140
13.3 Post Market Surveillance (PMS) 141
14 Pricing
and Reimbursement 142
14.1 Market Pricing 142
14.2 Government Policies
for Reimbursement 142
15 Distribution Structure 144
16 Financial Deals
Landscape 145
16.1 Acquisition 145
16.1.1 Mundipharma International
Acquires Clinical Designs From Abingworth Management 145
17 Recent
Developments 147
17.1 Strategy And Business Planning 147
17.1.1 Jun
13, 2008: GE Healthcare Plans To Establish A Regional Headquarters In
Istanbul, Turkey 147
17.2 Corporate Communications 147
17.2.1 Jul 17,
2008: GE Health Care Appoints New CEO 147
17.2.2 Jun 09, 2008: Oxford
Nanopore Announces Senior Management Appointments 148
17.2.3 May 21, 2008:
SkyePharma Announces Executive Succession Plan 149
17.2.4 May 08, 2008:
Farfield Appoints US Product Manager 149
17.2.5 Mar 27, 2008: SkyePharma
Non-Executive Director To Resign 150
17.2.6 Mar 24, 2008: Glide
Pharmaceutical Announces Management Appointments 150
18 Appendix 151
18.1 Global Markets Direct Research Methodology 151
18.2 Coverage 152
18.3 Secondary Research 152
18.4 Primary Research 153
18.5 Models
153
18.6 Forecasts 154
18.7 Expert Panels 154
18.8 Currency
Conversion 155
18.9 Contact Us 156
18.10 Disclaimer 156
1.1
List of Tables
Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
17
Table 2: Drug Delivery Devices, United Kingdom, Overall Revenues ($
mn), 2000-2012 19
Table 3: Drug Delivery Devices, United Kingdom, Overall
Revenues ($ mn), Historic, 2000-2007 20
Table 4: Drug Delivery Devices,
United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 21
Table 5:
Drug Delivery Devices, United Kingdom, Category Revenues ($ mn), 2000-2012
22
Table 6: Drug Delivery Devices, United Kingdom, Category Revenues ($
mn), Historic, 2000-2007 23
Table 7: Drug Delivery Devices, United
Kingdom, Category Revenues ($ mn), Forecast, 2007-2012 24
Table 8: Drug
Delivery Devices, United Kingdom, Category Volume (Units), 2000-2012 25
Table 9: Drug Delivery Devices, United Kingdom, Category Volume (Units),
Historic, 2000-2007 26
Table 10: Drug Delivery Devices, United Kingdom,
Category Volume (Units), Forecast, 2007-2012 27
Table 11: Drug Delivery
Devices, United Kingdom, Company Share by Revenue ($ mn), 2005-2006 28
Table 12: Inhalation Systems, United Kingdom, Overall Revenues ($ mn),
Historic, 2000-2007 29
Table 13: Inhalation Systems, United Kingdom,
Overall Revenues ($ mn), Forecast, 2007-2012 30
Table 14: Inhalation
Systems, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007 31
Table 15: Inhalation Systems, United Kingdom, Revenue by Segment ($ mn),
Forecast, 2007-2012 32
Table 16: Metered Dose Inhaler Devices, United
Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 33
Table 17: Metered
Dose Inhaler Devices, United Kingdom, Overall Revenues ($ mn), Forecast,
2007-2012 34
Table 18: Dry Powder Inhaler Devices, United Kingdom, Overall
Revenues ($ mn), Historic, 2000-2007 35
Table 19: Dry Powder Inhaler
Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 36
Table 20: Inhalation Systems, United Kingdom, Overall Volume (Units),
Historic, 2000-2007 37
Table 21: Inhalation Systems, United Kingdom,
Overall Volume (Units), Forecast, 2007-2012 38
Table 22: Metered Dose
Inhaler Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007
39
Table 23: Metered Dose Inhaler Devices, United Kingdom, Overall Volume
(Units), Forecast, 2007-2012 40
Table 24: Dry Powder Inhaler Devices,
United Kingdom, Overall Volume (Units), Historic, 2000-2007 41
Table 25:
Dry Powder Inhaler Devices, United Kingdom, Overall Volume (Units), Forecast,
2007-2012 42
Table 26: Metered Dose Inhaler Devices, United Kingdom,
Average Price ($), Historic, 2000-2007 43
Table 27: Metered Dose Inhaler
Devices, United Kingdom, Average Price ($), Forecast, 2007-2012 44
Table
28: Dry Powder Inhaler Devices, United Kingdom, Average Price ($), Historic,
2000-2007 45
Table 29: Dry Powder Inhaler Devices, United Kingdom, Average
Price ($), Forecast, 2007-2012 46
Table 30: Inhalation Systems, United
Kingdom, Distribution Share by Revenue ($ mn), 2005-2006 47
Table 31:
Inhalation Systems, United Kingdom, Company Share by Revenue ($ mn), 2005-2006
48
Table 32: Infusion Systems, United Kingdom, Overall Revenues ($ mn),
Historic, 2000-2007 49
Table 33: Infusion Systems, United Kingdom, Overall
Revenues ($ mn), Forecast, 2007-2012 50
Table 34: Infusion Systems, United
Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007 51
Table 35:
Infusion Systems, United Kingdom, Revenue by Segment ($ mn), Forecast,
2007-2012 52
Table 36: Infusion Disposable Sets, United Kingdom, Overall
Revenues ($ mn), Historic, 2000-2007 53
Table 37: Infusion Disposable
Sets, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 54
Table 38: Infusion Pumps, United Kingdom, Overall Revenues ($ mn), Historic,
2000-2007 55
Table 39: Infusion Pumps, United Kingdom, Overall Revenues ($
mn), Forecast, 2007-2012 56
Table 40: Syringe Pumps, United Kingdom,
Overall Revenues ($ mn), Historic, 2000-2007 57
Table 41: Syringe Pumps,
United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 58
Table 42:
Infusion Systems, United Kingdom, Overall Volume (Units), Historic, 2000-2007
59
Table 43: Infusion Systems, United Kingdom, Overall Volume (Units),
Forecast, 2007-2012 59
Table 44: Infusion Disposable Sets, United Kingdom,
Overall Volume (Units), Historic, 2000-2007 60
Table 45: Infusion
Disposable Sets, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
61
Table 46: Infusion Pumps, United Kingdom, Overall Volume (Units),
Historic, 2000-2007 62
Table 47: Infusion Pumps, United Kingdom, Overall
Volume (Units), Forecast, 2007-2012 63
Table 48: Syringe Pumps, United
Kingdom, Overall Volume (Units), Historic, 2000-2007 64
Table 49: Syringe
Pumps, United Kingdom, Overall Volume (Units), Forecast, 2007-2012 65
Table 50: Infusion Pumps, United Kingdom, Average Price ($), Historic,
2000-2007 66
Table 51: Infusion Pumps, United Kingdom, Average Price ($),
Forecast, 2007-2012 67
Table 52: Syringe Pumps, United Kingdom, Average
Price ($), Historic, 2000-2007 68
Table 53: Syringe Pumps, United Kingdom,
Average Price ($), Forecast, 2007-2012 69
Table 54: Infusion Disposable
Sets, United Kingdom, Average Price ($), Historic, 2000-2007 70
Table 55:
Infusion Disposable Sets, United Kingdom, Average Price ($), Historic,
2000-2007 71
Table 56: Infusion Systems, United Kingdom, Distribution
Share by Revenue ($ mn), 2005-2006 72
Table 57: Infusion Systems, United
Kingdom, Company Share by Revenue ($ mn), 2005-2006 73
Table 58: Needle
Free Injections, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
74
Table 59: Needle Free Injections, United Kingdom, Overall Revenues ($
mn), Forecast, 2007-2012 75
Table 60: Needle Free Injections, United
Kingdom, Overall Volume (Units), Historic, 2000-2007 76
Table 61: Needle
Free Injections, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
77
Table 62: Needle Free Injections, United Kingdom, Average Price ($),
Historic, 2000-2007 78
Table 63: Needle Free Injections, United Kingdom,
Average Price ($), Forecast, 2007-2012 79
Table 64: Needle Free
Injections, United Kingdom, Distribution Share by Revenue ($ mn), 2005-2006
80
Table 65: Needle Free Injections, United Kingdom, Company Share by
Revenue ($ mn), 2005-2006 81
Table 66: AstraZeneca PLC, Subsidiaries
85
Table 67: AstraZeneca PLC, Subsidiaries(Contd..) 86
Table 68:
3M Company, SWOT Analysis, 2006 95
Table 69: 3M Company, Revenue
by Segment, USD Million, 2003-2007 98
Table 70: 3M Company, Revenue
by Geography, USD Million, 2003-2007 99
Table 71: 3M Company,
Financial Statements, USD Million, 2003-2007 100
Table 72: 3M
Company, Financial Ratios, USD Million, 2003-2007 101
Table 73: 3M
Company, Subsidiaries 102
Table 74: Baxter International Inc., SWOT
Analysis, 2006 109
Table 75: Baxter International Inc., Revenue by
Segment, USD Million, 2003-2007 112
Table 76: Baxter International
Inc., Revenue by Geography, USD Million, 2003-2007 113
Table 77:
Baxter International Inc., Financial Statements, USD Million, 2003-2007
114
Table 78: Baxter International Inc., Financial Ratios, USD
Million, 2003-2007 115
Table 79: Baxter International Inc., Other
Locations 116
Table 80: Baxter International Inc., Subsidiaries
117
Table 81: GlaxoSmithKline plc, Subsidiaries 123
Table 82:
Novartis Medical Nutrition, Other Locations 126
Table 83: Novartis
Medical Nutrition, Other Locations(Contd..) 127
Table 84: Medical Device
Approval Fee in UK, 2006 141
Table 85: Currency Conversion from USD to
Local Currency at 2007 Constant Rate 155
1.2 List of Figures
Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006 16
Figure 2:
Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
19
Figure 3: Drug Delivery Devices, United Kingdom, Overall Revenues ($
mn), Historic, 2000-2007 20
Figure 4: Drug Delivery Devices, United
Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 21
Figure 5: Drug
Delivery Devices, United Kingdom, Category Revenues ($ mn), 2000-2012 22
Figure 6: Drug Delivery Devices, United Kingdom, Category Revenues ($ mn),
Historic, 2000-2007 23
Figure 7: Drug Delivery Devices, United Kingdom,
Category Revenues ($ mn), Forecast, 2007-2012 24
Figure 8: Drug Delivery
Devices, United Kingdom, Category Volume (Units), 2000-2012 25
Figure 9:
Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic,
2000-2007 26
Figure 10: Drug Delivery Devices, United Kingdom, Category
Volume (Units), Forecast, 2007-2012 27
Figure 11: Drug Delivery Devices,
United Kingdom, Company Share (%), 2006 28
Figure 12: Inhalation Systems,
United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 29
Figure 13:
Inhalation Systems, United Kingdom, Overall Revenues ($ mn), Forecast,
2007-2012 30
Figure 14: Inhalation Systems, United Kingdom, Revenue by
Segment ($ mn), Historic, 2000-2007 31
Figure 15: Inhalation Systems,
United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012 32
Figure
16: Metered Dose Inhaler Devices, United Kingdom, Overall Revenues ($ mn),
Historic, 2000-2007 33
Figure 17: Metered Dose Inhaler Devices, United
Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 34
Figure 18: Dry
Powder Inhaler Devices, United Kingdom, Overall Revenues ($ mn), Historic,
2000-2007 35
Figure 19: Dry Powder Inhaler Devices, United Kingdom,
Overall Revenues ($ mn), Forecast, 2007-2012 36
Figure 20: Inhalation
Systems, United Kingdom, Overall Volume (Units), Historic, 2000-2007 37
Figure 21: Inhalation Systems, United Kingdom, Overall Volume (Units),
Forecast, 2007-2012 38
Figure 22: Metered Dose Inhaler Devices, United
Kingdom, Overall Volume (Units), Historic, 2000-2007 39
Figure 23: Metered
Dose Inhaler Devices, United Kingdom, Overall Volume (Units), Forecast,
2007-2012 40
Figure 24: Dry Powder Inhaler Devices, United Kingdom,
Overall Volume (Units), Historic, 2000-2007 41
Figure 25: Dry Powder
Inhaler Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
42
Figure 26: Metered Dose Inhaler Devices, United Kingdom, Average Price
($), Historic, 2000-2007 43
Figure 27: Metered Dose Inhaler Devices,
United Kingdom, Average Price ($), Forecast, 2007-2012 44
Figure 28: Dry
Powder Inhaler Devices, United Kingdom, Average Price ($), Historic, 2000-2007
45
Figure 29: Dry Powder Inhaler Devices, United Kingdom, Average Price
($), Forecast, 2007-2012 46
Figure 30: Inhalation Systems, United Kingdom,
Distribution Share (%), 2006 47
Figure 31: Inhalation Systems, United
Kingdom, Company Share (%), 2006 48
Figure 32: Infusion Systems, United
Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 49
Figure 33:
Infusion Systems, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
50
Figure 34: Infusion Systems, United Kingdom, Revenue by Segment ($ mn),
Historic, 2000-2007 51
Figure 35: Infusion Systems, United Kingdom,
Revenue by Segment ($ mn), Forecast, 2007-2012 52
Figure 36: Infusion
Disposable Sets, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
53
Figure 37: Infusion Disposable Sets, United Kingdom, Overall Revenues
($ mn), Forecast, 2007-2012 54
Figure 38: Infusion Pumps, United Kingdom,
Overall Revenues ($ mn), Historic, 2000-2007 55
Figure 39: Infusion Pumps,
United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 56
Figure 40:
Syringe Pumps, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
57
Figure 41: Syringe Pumps, United Kingdom, Overall Revenues ($ mn),
Forecast, 2007-2012 58
Figure 42: Infusion Disposable Sets, United
Kingdom, Overall Volume (Units), Historic, 2000-2007 60
Figure 43:
Infusion Disposable Sets, United Kingdom, Overall Volume (Units), Forecast,
2007-2012 61
Figure 44: Infusion Pumps, United Kingdom, Overall Volume
(Units), Historic, 2000-2007 62
Figure 45: Infusion Pumps, United Kingdom,
Overall Volume (Units), Forecast, 2007-2012 63
Figure 46: Syringe Pumps,
United Kingdom, Overall Volume (Units), Historic, 2000-2007 64
Figure 47:
Syringe Pumps, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
65
Figure 48: Infusion Pumps, United Kingdom, Average Price ($), Historic,
2000-2007 66
Figure 49: Infusion Pumps, United Kingdom, Average Price ($),
Forecast, 2007-2012 67
Figure 50: Syringe Pumps, United Kingdom, Average
Price ($), Historic, 2000-2007 68
Figure 51: Syringe Pumps, United
Kingdom, Average Price ($), Forecast, 2007-2012 69
Figure 52: Infusion
Disposable Sets, United Kingdom, Average Price ($), Historic, 2000-2007 70
Figure 53: Infusion Disposable Sets, United Kingdom, Average Price ($),
Forecast, 2007-2012 71
Figure 54: Infusion Systems, United Kingdom,
Distribution Share (%), 2006 72
Figure 55: Infusion Systems, United
Kingdom, Company Share (%), 2006 73
Figure 56: Needle Free Injections,
United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 74
Figure 57:
Needle Free Injections, United Kingdom, Overall Revenues ($ mn), Forecast,
2007-2012 75
Figure 58: Needle Free Injections, United Kingdom, Overall
Volume (Units), Historic, 2000-2007 76
Figure 59: Needle Free Injections,
United Kingdom, Overall Volume (Units), Forecast, 2007-2012 77
Figure 60:
Needle Free Injections, United Kingdom, Average Price ($), Historic, 2000-2007
78
Figure 61: Needle Free Injections, United Kingdom, Average Price ($),
Forecast, 2007-2012 79
Figure 62: Needle Free Injections, United Kingdom,
Distribution Share (%), 2006 80
Figure 63: 3M Company, Value Chain
Analysis 93
Figure 64: Baxter International Inc., Value Chain
Analysis 107
Figure 65: Flowchart for Classification of Non-invasive
Devices in UK, 2007 129
Figure 66: Flowchart for Classification of
Invasive Devices in UK, 2007 130
Figure 67: Flowchart for Classification
of Invasive Devices in UK, 2007 131
Figure 68: Flowchart for
Classification of Invasive Devices in UK, 2007 132
Figure 69: Flowchart
for Classification of Invasive Devices in UK, 2007 133
Figure 70:
Flowchart for Classification of Active Devices in UK, 2007 134
Figure 71:
Flowchart for Classification of Active Devices in UK, 2007 135
Figure 72:
Flowchart for Classification of Devices except Non-invasive, Invasive and
Active Devices in UK, 2007 136
Figure 73: Conformity Assessment of Class-I
Medical Devices in UK, 2007 137
Figure 74: Conformity Assessment of
Class-IIa Medical Devices in UK, 2007 138
Figure 75: Conformity Assessment
of Class-IIb Medical Devices in UK, 2007 139
Figure 76: Conformity
Assessment of Class-III Medical Devices in UK, 2007 140
Figure 77: Global
Markets Direct Methodology 151
View Cart
